Profile data is unavailable for this security.
About the company
National Research Corporation, doing business as NRC Health, is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare organizations in the United States. Its digital solutions consist of three primary solution categories: Marketing, Reputation and Experience. Its Marketing solutions are subscription-based services that allow for improved tracking of awareness, perception, and consistency of healthcare brands; real-time assessment of competitive differentiators, and enhanced segmentation tools to evaluate the needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. The Company's Experience solutions are provided on a subscription basis via a cross-continuum multi-mode digital platform. Its Reputation solutions allow healthcare organizations to share a picture of their organization.
- Revenue in USD (TTM)148.58m
- Net income in USD30.96m
- Incorporated1997
- Employees435.00
- LocationNational Research Corp1245 Q StLINCOLN 68508United StatesUSA
- Phone+1 (402) 475-2525
- Fax+1 (402) 475-9061
- Websitehttps://nrchealth.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SS Innovations International Inc | 5.88m | -20.94m | 768.26m | 239.00 | -- | 53.73 | -- | 130.66 | -0.1293 | -0.1293 | 0.04 | 0.0838 | 0.3939 | -- | 2.53 | 24,601.30 | -140.31 | -161.38 | -253.40 | -449.76 | 12.13 | -79.79 | -356.17 | -495.77 | 1.30 | -52.51 | 0.2963 | -- | -- | -- | -846.31 | -- | 159.31 | -- |
ALX Oncology Holdings Inc | 0.00 | -160.81m | 775.66m | 72.00 | -- | 4.04 | -- | -- | -3.74 | -3.74 | 0.00 | 3.80 | 0.00 | -- | -- | 0.00 | -58.58 | -34.34 | -66.35 | -36.47 | -- | -- | -- | -7,238.76 | -- | -- | 0.0592 | -- | -- | -- | -30.23 | -- | 14.30 | -- |
Nuvation Bio Inc | 0.00 | -75.80m | 794.35m | 51.00 | -- | 1.17 | -- | -- | -0.3463 | -0.3463 | 0.00 | 2.76 | 0.00 | -- | -- | 0.00 | -11.72 | -16.27 | -11.97 | -16.65 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 27.25 | -- | -- | -- |
CARGO Therapeutics Inc | 0.00 | -98.15m | 800.36m | 116.00 | -- | 2.07 | -- | -- | -2.37 | -2.37 | 0.00 | 9.84 | -- | -- | -- | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -139.67 | -- | -- | -- |
Tango Therapeutics Inc | 36.53m | -101.74m | 812.13m | 140.00 | -- | 3.07 | -- | 22.23 | -1.08 | -1.08 | 0.3865 | 2.48 | 0.0871 | -- | 36.53 | 260,907.10 | -24.25 | -- | -27.59 | -- | -- | -- | -278.54 | -- | -- | -- | 0.00 | -- | 46.93 | -- | 5.95 | -- | -- | -- |
Evolus Inc | 202.09m | -61.69m | 816.28m | 273.00 | -- | -- | -- | 4.04 | -1.08 | -1.08 | 3.55 | -0.3578 | 1.10 | 4.12 | 7.63 | 740,238.10 | -33.62 | -40.92 | -45.33 | -59.74 | 69.54 | 65.43 | -30.52 | -80.46 | 2.10 | -3.47 | 1.21 | -- | 35.98 | -- | 17.10 | -- | 182.77 | -- |
Regenxbio Inc | 90.24m | -263.49m | 825.39m | 344.00 | -- | 2.38 | -- | 9.15 | -6.03 | -6.03 | 2.06 | 7.08 | 0.1283 | -- | 3.41 | 262,331.40 | -37.45 | -16.75 | -45.96 | -19.08 | 58.76 | 78.27 | -291.99 | -72.06 | -- | -- | 0.00 | -- | -19.94 | -16.21 | 6.00 | -- | -5.59 | -- |
Zentalis Pharmaceuticals Inc | 0.00 | -292.19m | 830.94m | 168.00 | -- | 1.90 | -- | -- | -4.56 | -4.56 | 0.00 | 6.18 | 0.00 | -- | -- | 0.00 | -50.65 | -47.40 | -57.28 | -54.18 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.39 | -- | 20.76 | -- |
Longboard Pharmaceuticals Inc | 0.00 | -54.42m | 831.06m | 50.00 | -- | 12.81 | -- | -- | -2.39 | -2.39 | 0.00 | 1.67 | 0.00 | -- | -- | 0.00 | -89.72 | -- | -105.91 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.84 | -- | -- | -- |
National Research Corporation | 148.58m | 30.96m | 832.40m | 435.00 | 27.77 | 17.25 | 22.58 | 5.60 | 1.26 | 1.26 | 6.02 | 2.02 | 1.18 | -- | 11.00 | 341,563.20 | 24.49 | 26.25 | 33.80 | 36.77 | 62.30 | 63.20 | 20.84 | 23.95 | -- | 1,929.64 | 0.4286 | 55.45 | -1.97 | 4.42 | -2.58 | 0.6695 | 21.45 | -5.29 |
SAGE Therapeutics Inc | 91.06m | -503.14m | 838.94m | 487.00 | -- | 1.19 | -- | 9.21 | -8.40 | -8.40 | 1.52 | 11.73 | 0.0916 | -- | 6.26 | 186,989.70 | -50.61 | -21.88 | -54.64 | -23.30 | 96.49 | 99.63 | -552.52 | -131.50 | -- | -- | 0.00 | -- | 1,024.84 | -0.8606 | -1.63 | -- | -28.01 | -- |
Pliant Therapeutics Inc | 1.58m | -161.34m | 843.26m | 158.00 | -- | 1.77 | -- | 533.71 | -2.75 | -2.75 | 0.0269 | 7.90 | 0.0037 | -- | 1.59 | 10,000.00 | -37.40 | -33.24 | -39.82 | -35.39 | -- | -- | -10,211.14 | -360.29 | -- | -- | 0.0208 | -- | -83.69 | -- | -30.83 | -- | -16.89 | -- |
USANA Health Sciences, Inc. | 900.45m | 61.94m | 876.41m | 1.80k | 14.22 | 1.75 | 15.98 | 0.9733 | 3.20 | 3.20 | 46.56 | 25.99 | 1.46 | 2.73 | -- | 500,250.00 | 10.03 | 16.23 | 12.49 | 21.75 | 80.98 | 81.42 | 6.88 | 8.96 | 3.20 | -- | 0.0026 | 0.00 | -7.77 | -4.98 | -8.02 | -12.76 | 4.86 | -- |
89bio Inc | 0.00 | -142.19m | 877.97m | 70.00 | -- | 1.60 | -- | -- | -2.01 | -2.01 | 0.00 | 5.75 | 0.00 | -- | -- | 0.00 | -35.86 | -45.50 | -38.49 | -49.31 | -- | -- | -- | -- | -- | -- | 0.0442 | -- | -- | -- | -39.37 | -- | -36.58 | -- |
OPKO Health Inc | 863.49m | -188.86m | 906.09m | 3.93k | -- | 0.7236 | -- | 1.05 | -0.2513 | -0.2513 | 1.15 | 1.80 | 0.4133 | 7.80 | 6.89 | 219,718.60 | -9.03 | -7.14 | -10.03 | -8.14 | 36.84 | 34.42 | -21.86 | -13.83 | 1.22 | -15.24 | 0.1574 | -- | -14.01 | -2.70 | 42.49 | -- | -10.19 | -- |
Holder | Shares | % Held |
---|---|---|
Kayne Anderson Rudnick Investment Management LLCas of 29 Feb 2024 | 3.19m | 13.38% |
BlackRock Fund Advisorsas of 31 Dec 2023 | 959.03k | 4.02% |
The Vanguard Group, Inc.as of 31 Dec 2023 | 896.21k | 3.76% |
Atlanta Capital Management Co. LLCas of 31 Dec 2023 | 891.84k | 3.74% |
Conestoga Capital Advisors LLCas of 31 Mar 2024 | 784.66k | 3.29% |
Dimensional Fund Advisors LPas of 31 Dec 2023 | 636.40k | 2.67% |
Renaissance Technologies LLCas of 31 Dec 2023 | 373.58k | 1.57% |
Geode Capital Management LLCas of 31 Dec 2023 | 356.31k | 1.49% |
SSgA Funds Management, Inc.as of 31 Dec 2023 | 342.48k | 1.44% |
QV Investors, Inc.as of 31 Mar 2024 | 342.25k | 1.44% |